Back to Search
SANDHYA KHARBANDA, M.D.
M.D.
Pediatric Hematology & Oncology Physician
NPI: 1750498226IndividualAccepts Medicare
Specialties, Licenses & Credentials
Pediatric Hematology & Oncology PhysicianPrimary
Pediatrics — Pediatric Hematology-Oncology
Code: 2080P0207X
25813(AL)
Education
OTHER
Class of 1993
Research & Publications (20)
Inflammatory cytokines and the development of pulmonary complications after allogeneic hematopoietic cell transplantation in patients with inherited metabolic storage disorders.
PMID 16545727·Biol Blood Marrow Transplant·2006
3-trial
Regulation of the hTERT telomerase catalytic subunit by the c-Abl tyrosine kinase.
PMID 10837221·Curr Biol·2000
8-other
Translocation of SAPK/JNK to mitochondria and interaction with Bcl-x(L) in response to DNA damage.
PMID 10617621·J Biol Chem·2000
8-other
Activation of MEK kinase 1 by the c-Abl protein tyrosine kinase in response to DNA damage.
PMID 10866655·Mol Cell Biol·2000
7-preclinical
MUC1 oncoprotein promotes autophagy in a survival response to glucose deprivation.
PMID 19424588·Int J Oncol·2009
8-other
Direct targeting of the mucin 1 oncoprotein blocks survival and tumorigenicity of human breast carcinoma cells.
PMID 19491255·Cancer Res·2009
7-preclinical
Stable long-term donor engraftment following reduced-intensity hematopoietic cell transplantation for sickle cell disease.
PMID 18940682·Biol Blood Marrow Transplant·2008
3-trial
MUC1 oncoprotein suppresses activation of the ARF-MDM2-p53 pathway.
PMID 18981727·Cancer Biol Ther·2008
8-other
MUC1 oncoprotein blocks death receptor-mediated apoptosis by inhibiting recruitment of caspase-8.
PMID 18676836·Cancer Res·2008
8-other
Glioblastoma-derived stem cell-enriched cultures form distinct subgroups according to molecular and phenotypic criteria.
PMID 18037961·Oncogene·2008
4-observational
Identification of IGF2 signaling through phosphoinositide-3-kinase regulatory subunit 3 as a growth-promoting axis in glioblastoma.
PMID 17360667·Proc Natl Acad Sci U S A·2007
4-observational
Epigenome scans and cancer genome sequencing converge on WNK2, a kinase-independent suppressor of cell growth.
PMID 17578925·Proc Natl Acad Sci U S A·2007
8-other
The MUC1 and galectin-3 oncoproteins function in a microRNA-dependent regulatory loop.
PMID 17889671·Mol Cell·2007
7-preclinical
Mucin 1 oncoprotein blocks hypoxia-inducible factor 1alpha activation in a survival response to hypoxia.
PMID 17102128·J Biol Chem·2007
8-other
A novel isocoumarin derivative induces mitotic phase arrest and apoptosis of human multiple myeloma cells.
PMID 16830153·Cancer Chemother Pharmacol·2007
8-other
MUC1 oncoprotein activates the IkappaB kinase beta complex and constitutive NF-kappaB signalling.
PMID 18037881·Nat Cell Biol·2007
8-other
Distinct evolution of the human carcinoma-associated transmembrane mucins, MUC1, MUC4 AND MUC16.
PMID 16500040·Gene·2006
7-preclinical
Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis.
PMID 16530701·Cancer Cell·2006
4-observational
MUC1 oncoprotein blocks nuclear targeting of c-Abl in the apoptotic response to DNA damage.
PMID 16888623·EMBO J·2006
8-other
Triterpenoid CDDO-Me blocks the NF-kappaB pathway by direct inhibition of IKKbeta on Cys-179.
PMID 16998237·J Biol Chem·2006
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 1600 7TH AVE S
BIRMINGHAM, AL 35233 - Phone
- (205) 939-9285
Quick Facts
- NPI
- 1750498226
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 2
- Years in Practice
- 33
- Publications
- 20
Are you this provider?
Claim Your Profile